ENZO BIOCHEM, INC. Deferred Revenue
ENZO BIOCHEM, INC. had Deferred Revenue of $1.99 million as of 2022-04-30, per its 10-Q filed 2022-06-09.
Discontinued › Balance Sheet › Liabilities
us-gaap:DeferredRevenue · last filed 2022-06-09
- 2022-04-30: Deferred Revenue $1.99M.
- 2022-01-31: Deferred Revenue $2.11M.
- 2021-10-31: Deferred Revenue $3.12M.
- 2021-07-31: Deferred Revenue $2.59M.
| Period end | Deferred Revenue |
|---|---|
| 2022-04-30 | $1.99M 10-Q · filed 2022-06-09 |
| 2022-01-31 | $2.11M 10-Q · filed 2022-03-14 |
| 2021-10-31 | $3.12M 10-Q · filed 2021-12-15 |
| 2021-07-31 | $2.59M 10-Q · filed 2022-06-09 |
| 2021-04-30 | $2.31M 10-Q · filed 2021-06-11 |
| 2021-01-31 | $2.12M 10-Q · filed 2021-03-16 |
| 2020-10-31 | $3.27M 10-Q · filed 2020-12-11 |
| 2020-07-31 | $1.72M 10-K · filed 2021-10-12 |
| 2020-04-30 | $1.18M 10-Q · filed 2020-06-09 |
| 2019-07-31 | $2.30M 10-K · filed 2020-10-19 |
| 2011-07-31 | $396.00K 10-K · filed 2012-10-15 |